Thus, this is the first systematic review and meta-analysis undertaken to better understand the mechanisms and pathways concerning the involvement of PD-1/PDL-1 in HCC immunotherapy, ICI, and TME. The gene discussed is CD274; the disease is hepatocellular carcinoma.